TGFB1 and IL8 gene polymorphisms and susceptibility to visceral leishmaniasis

Infection, Genetics and Evolution

Volumn 11, Issue 5, 2011, Pages 912-916

  Frade, Amanda Farage ^a   Oliveira, Lea Campos de ^a   Costa, Dorcas Lamounier ^d   Costa, Carlos Henrique Nery ^d   Aquino, Dorlene ^b   Van Weyenbergh, Johan ^c,f   Barral Netto, Manoel ^c,f   Barral, Aldina ^c,e,f   Kalil, Jorge ^a,f   Goldberg, Anna Carla ^e,f  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^e Albert Einstein Jewish Institute for Education and Research   (Brazil)

^f Inst for Investigation in Immunology (iii)   (Brazil)

Author keywords

Cytokines; Disease susceptibility; Gene polymorphisms; Visceral leishmaniasis

Indexed keywords

ADENINE; CYTOSINE; INTERLEUKIN 8; THYMINE; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IL8 GENE; INFANT; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM; TGFB1 GENE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INTERLEUKIN-8; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1;

NASO HEXACANTHUS; PROTOZOA;

EID: 79956291785     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.02.014     Document Type: Article

References (39)

1. Ansari N.A., Saluja S., Salotra P. Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin. Immunol. 2006, 119:339-345.
2. Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A., Ellingsworth L.R., Twardzik D.R., Reed S.G. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992, 257:545-548.
3. Belluco C., Olivieri F., Bonafè M., Giovagnetti S., Mammano E., Scalerta R., Ambrosi A., Franceschi C., Nitti D., Lise M. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin. Cancer Res. 2003, 9:2173-2176.
4. Berman J. Visceral leishmaniasis in the New World & Africa. Indian J. Med. Res. 2006, 123:289-294.
5. Bern C., Amann J., Haque R., Chowdhury R., Ali M., Kurkjian K.M., Vaz L., Wagatsuma Y., Breiman R.F., Secor W.E., Maguire J.H. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. Am. J. Trop. Med. Hyg. 2006, 75:744-748.
6. Blackwell J.M. Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int. J. Parasitol. 1998, 28:21-28.
7. Blackwell J.M., Black G.F., Peacock C.S., Miller E.N., Sibthorpe D., Gnananandha D., Shaw J.J., Silveira F., Lins-Lainson Z., Ramos F., Collins A., Shaw M.A. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Philos. Trans. R Soc. London B: Biol. Sci. 1997, 352:1331-1345.
8. Bogdan C., Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci. 1993, 685:713-739.
9. Caldas A., Favali C., Aquino D., Vinhas V., van Weyenbergh J., Brodskyn C., Costa J., Barral-Netto M., Barral A. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect. Dis. 2005, 5:113.
10. Caldas A.J., Costa J.M., Silva A.A., Vinhas V., Barral A. Risk factors associated with asymptomatic infection by Leishmania chagasi in north-east Brazil. Trans. R Soc. Trop. Med. Hyg. 2002, 96:21-28.
11. Castell J.V., Andus T., Kunz D., Heinrich P.C. Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann. N. Y. Acad. Sci. 1989, 557:87-99. (discussion 100-101).
12. Castellucci L., Menezes E., Oliveira J., Magalhaes A., Guimaraes L.H., Lessa M., Ribeiro S., Reale J., Noronha E.F., Wilson M.E., Duggal P., Beaty T.H., Jeronimo S., Jamieson S.E., Bales A., Blackwell J.M., de Jesus A.R., Carvalho E.M. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J. Infect. Dis. 2006, 194:519-527.
13. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
14. Farouk S., Salih M.A., Musa A.M., Blackwell J.M., Miller E.N., Khalil E.A., Elhassan A.M., Ibrahim M.E., Mohamed H.S. Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population. Public Health Genomics 2010, 13:362-367.
15. Gantt K.R., Schultz-Cherry S., Rodriguez N., Jeronimo S.M., Nascimento E.T., Goldman T.L., Recker T.J., Miller M.A., Wilson M.E. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J. Immunol. 2003, 170:2613-2620.
16. Gleizes P.E., Munger J.S., Nunes I., Harpel J.G., Mazzieri R., Noguera I., Rifkin D.B. TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 1997, 15:190-197.
17. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., Spector T.D. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 1999, 8:93-97.
18. Gustincich S., Manfioletti G., Del Sal G., Schneider C., Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991, 11(298-300):302.
19. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 1994, 56:559-564.
20. Hulkkonen J., Pertovaara M., Antonen J., Lahdenpohja N., Pasternack A., Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum. 2001, 44:176-179.
21. Hull J., Rowlands K., Lockhart E., Sharland M., Moore C., Hanchard N., Kwiatkowski D.P. Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum. Genet. 2004, 114:272-279.
22. Jeronimo S.M., Holst A.K., Jamieson S.E., Francis R., Martins D.R., Bezerra F.L., Ettinger N.A., Nascimento E.T., Monteiro G.R., Lacerda H.G., Miller E.N., Cordell H.J., Duggal P., Beaty T.H., Blackwell J.M., Wilson M.E. Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun. 2007, 8:539-551.
23. Karplus T.M., Jeronimo S.M., Chang H., Helms B.K., Burns T.L., Murray J.C., Mitchell A.A., Pugh E.W., Braz R.F., Bezerra F.L., Wilson M.E. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect. Immun. 2002, 70:6919-6925.
24. Kaye P.M., Svensson M., Ato M., Maroof A., Polley R., Stager S., Zubairi S., Engwerda C.R. The immunopathology of experimental visceral leishmaniasis. Immunol. Rev. 2004, 201:239-253.
25. Kumar D., Kulshrestha A., Singh R., Salotra P. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob. Agents Chemother. 2009, 53:835-838.
26. Lee W.P., Tai D.I., Lan K.H., Li A.F., Hsu H.C., Lin E.J., Lin Y.P., Sheu M.L., Li C.P., Chang F.Y., Chao Y., Yen S.H., Lee S.D. The -251 T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 2005, 11:6431-6441.
27. Lurje G., Zhang W., Schultheis A.M., Yang D., Groshen S., Hendifar A.E., Husain H., Gordon M.A., Nagashima F., Chang H.M., Lenz H.J. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann. Oncol. 2008, 19:1734-1741.
28. Malla N., Mahajan R.C. Pathophysiology of visceral leishmaniasis - some recent concepts. Indian J. Med. Res. 2006, 123:267-274.
29. Mohamed H.S., Ibrahim M.E., Miller E.N., Peacock C.S., Khalil E.A., Cordell H.J., Howson J.M., El Hassan A.M., Bereir R.E., Blackwell J.M. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun. 2003, 4:351-355.
30. Omer F.M., Kurtzhals J.A., Riley E.M. Maintaining the immunological balance in parasitic infections: a role for TGF-beta?. Parasitol. Today 2000, 16:18-23.
31. Peruhype-Magalhães V., Martins-Filho O.A., Prata A., Silva L.A., Rabello A., Teixeira-Carvalho A., Figueiredo R.M., Guimarães-Carvalho S.F., Ferrari T.C., Van Weyenbergh J., Correa-Oliveira R. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin. Exp. Immunol. 2006, 146:124-132.
32. Pulleyn L.J., Newton R., Adcock I.M., Barnes P.J. TGFbeta1 allele association with asthma severity. Hum. Genet. 2001, 109:623-627.
33. Rodrigues V., Santana da Silva J., Campos-Neto A. Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 1998, 66:1233-1236.
34. Saha S., Mondal S., Ravindran R., Bhowmick S., Modak D., Mallick S., Rahman M., Kar S., Goswami R., Guha S.K., Pramanik N., Saha B., Ali N. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J. Immunol. 2007, 179:5592-5603.
35. Sainz J., Perez E., Gomez-Lopera S., Lopez-Fernandez E., Moratalla L., Oyonarte S., Jurado M. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients. Cytokine 2008, 41:268-278.
36. Shrivastava A., Calame K. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res. 1994, 22:5151-5155.
37. van der Poll T., Zijlstra E.E., Mevissen M. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin. Immunol. Immunopathol. 1995, 77:111-114.
38. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 2004, 173:6521-6525.
39. Wong T.Y., Poon P., Chow K.M., Szeto C.C., Cheung M.K., Li P.K. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int. 2003, 63:1831-1835.